Literature DB >> 19818871

Lipotoxicity in the heart.

Adam R Wende1, E Dale Abel.   

Abstract

Obesity and insulin resistance are associated with ectopic lipid deposition in multiple tissues, including the heart. Excess lipid may be stored as triglycerides, but are also shunted into non-oxidative pathways that disrupt normal cellular signaling leading to organ dysfunction and in some cases apoptosis, a process termed lipotoxicity. Various pathophysiological mechanisms have been proposed to lead to lipotoxic tissue injury, which might vary by cell type. Specific mechanisms by which lipotoxicity alter cardiac structure and function are incompletely understood, but are beginning to be elucidated. This review will focus on mechanisms that have been proposed to lead to lipotoxic injury in the heart and will review the state of knowledge regarding potential causes and correlates of increased myocardial lipid content in animal models and humans. We will seek to highlight those areas where additional research is warranted. Copyright (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19818871      PMCID: PMC2823976          DOI: 10.1016/j.bbalip.2009.09.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  136 in total

Review 1.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

2.  Heart and blood pressure adaptations in Wistar rats fed with different high-fat diets for 18 months.

Authors:  Marcia B Aguila; Carlos Alberto Mandarim-de-Lacerda
Journal:  Nutrition       Date:  2003-04       Impact factor: 4.008

3.  Induction of adiponectin in skeletal muscle of type 2 diabetic mice: In vivo and in vitro studies.

Authors:  A M Delaigle; M Senou; Y Guiot; M-C Many; S M Brichard
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

4.  A metabolic role for mitochondria in palmitate-induced cardiac myocyte apoptosis.

Authors:  G C Sparagna; D L Hickson-Bick; L M Buja; J B McMillin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

5.  A critical role for eukaryotic elongation factor 1A-1 in lipotoxic cell death.

Authors:  Nica M Borradaile; Kimberly K Buhman; Laura L Listenberger; Carolyn J Magee; Emiko T A Morimoto; Daniel S Ory; Jean E Schaffer
Journal:  Mol Biol Cell       Date:  2005-11-30       Impact factor: 4.138

Review 6.  Role of diet and fuel overabundance in the development and progression of heart failure.

Authors:  David J Chess; William C Stanley
Journal:  Cardiovasc Res       Date:  2008-03-14       Impact factor: 10.787

Review 7.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

8.  Fatty acids and insulin modulate myocardial substrate metabolism in humans with type 1 diabetes.

Authors:  Linda R Peterson; Pilar Herrero; Janet McGill; Kenneth B Schechtman; Zulfia Kisrieva-Ware; Donna Lesniak; Robert J Gropler
Journal:  Diabetes       Date:  2007-10-03       Impact factor: 9.461

9.  Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus.

Authors:  Rutger W van der Meer; Luuk J Rijzewijk; Hugo W A M de Jong; Hildo J Lamb; Mark Lubberink; Johannes A Romijn; Jeroen J Bax; Albert de Roos; Otto Kamp; Walter J Paulus; Robert J Heine; Adriaan A Lammertsma; Johannes W A Smit; Michaela Diamant
Journal:  Circulation       Date:  2009-04-06       Impact factor: 29.690

10.  CD36 deficiency rescues lipotoxic cardiomyopathy.

Authors:  John Yang; Nandakumar Sambandam; Xianlin Han; Richard W Gross; Michael Courtois; Attila Kovacs; Maria Febbraio; Brian N Finck; Daniel P Kelly
Journal:  Circ Res       Date:  2007-03-15       Impact factor: 17.367

View more
  115 in total

1.  Enhancing fatty acid oxidation negatively regulates PPARs signaling in the heart.

Authors:  ZhengLong Liu; Jeffrey Ding; Timothy S McMillen; Outi Villet; Rong Tian; Dan Shao
Journal:  J Mol Cell Cardiol       Date:  2020-06-24       Impact factor: 5.000

2.  Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets.

Authors:  Pavan K Battiprolu; Thomas G Gillette; Zhao V Wang; Sergio Lavandero; Joseph A Hill
Journal:  Drug Discov Today Dis Mech       Date:  2010

Review 3.  Age-related cardiovascular disease and the beneficial effects of calorie restriction.

Authors:  Miranda M Y Sung; Jason R B Dyck
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

Review 4.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

5.  Insulin resistance is not associated with myocardial steatosis in women.

Authors:  M Krššák; Y Winhofer; C Göbl; M Bischof; G Reiter; A Kautzky-Willer; A Luger; M Krebs; C Anderwald
Journal:  Diabetologia       Date:  2011-04-15       Impact factor: 10.122

6.  Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload.

Authors:  Aly Elezaby; Aaron L Sverdlov; Vivian H Tu; Kanupriya Soni; Ivan Luptak; Fuzhong Qin; Marc Liesa; Orian S Shirihai; Jamie Rimer; Jean E Schaffer; Wilson S Colucci; Edward J Miller
Journal:  J Mol Cell Cardiol       Date:  2014-12-09       Impact factor: 5.000

7.  Cardiac steatosis potentiates angiotensin II effects in the heart.

Authors:  Denis J Glenn; Michelle C Cardema; Wei Ni; Yan Zhang; Yerem Yeghiazarians; Dmitry Grapov; Oliver Fiehn; David G Gardner
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 8.  Adipose tissue biology and cardiomyopathy: translational implications.

Authors:  Aslan T Turer; Joseph A Hill; Joel K Elmquist; Philipp E Scherer
Journal:  Circ Res       Date:  2012-12-07       Impact factor: 17.367

9.  Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.

Authors:  Michael E Hall; Matthew W Maready; John E Hall; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

10.  Long-term administration of angiotensin (1-7) prevents heart and lung dysfunction in a mouse model of type 2 diabetes (db/db) by reducing oxidative stress, inflammation and pathological remodeling.

Authors:  Anna M Papinska; Maira Soto; Christopher J Meeks; Kathleen E Rodgers
Journal:  Pharmacol Res       Date:  2016-03-05       Impact factor: 7.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.